Jennifer Evans Stacey's Net Worth
$643 Thousand
Who is Jennifer Evans Stacey?
Jennifer Evans Stacey does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ANTARES PHARMA, INC., Context Therapeutics Inc., Galera Therapeutics, Inc., and AUXILIUM PHARMACEUTICALS INC.
SEC CIK
Jennifer Evans Stacey's CIK is 0001321326
Past Insider Trading and Trends
2009 was Jennifer Evans Stacey's most active year for acquiring shares with 13 total transactions. Jennifer Evans Stacey's most active month to acquire stocks was the month of January. 2009 was Jennifer Evans Stacey's most active year for disposing of shares, totalling 13 transactions. Jennifer Evans Stacey's most active month to dispose stocks was the month of December. 2008 saw Jennifer Evans Stacey paying a total of $26,800.00 for 55,000 shares, this is the most they've acquired in one year. In 2009 Jennifer Evans Stacey cashed out on 38,400 shares for a total of $641,036.36, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ANTARES PHARMA, INC. No price found
SVP, General Counsel & Secty
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +279.21% | 67.77K |
$2.18 | -$5,382.42 | 92.04K |
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
|
∞
| 72.82K |
—
|
—
| 72.82K |
May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Context Therapeutics Inc. (CNTX) Snapshot price: $0.9601
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Galera Therapeutics, Inc. (GRTX) Snapshot price: $0.1709
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AUXILIUM PHARMACEUTICALS INC No price found
Executive VP & General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.28% | -941.00 |
$22.47 | -$21,144.27 | 16.88K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
| -5.02% | -941.00 |
$30.20 | -$28,418.20 | 17.82K |
Mar 12
| |||
Form 4
| +99.96% | 9.38K |
—
|
—
| 18.76K |
Feb 28
| |||
Form 4
|
—
|
0
|
$21.46 | -$176,959.71 | 9.38K |
Scheduled
|
Sep 14
| ||
Form 4
|
—
|
0
|
$19.81 | -$156,039.28 | 9.38K |
Scheduled
|
Jul 24
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
| +40.25% | 2.62K |
$30.00 | -$33,840.00 | 9.14K |
Jan 16
| |||
Form 4
|
—
|
0
|
$18.59 | -$136,684.81 | 6.51K |
Scheduled
|
Jan 6
| ||
Form 4
|
—
|
0
|
$16.48 | -$111,172.00 | 6.51K |
Scheduled
|
Dec 18
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
∞
| 5K |
$5.31 | $26,561.80 | 5K |
Nov 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||